Indian Journal of Sleep Medicine

Register      Login

VOLUME 9 , ISSUE 4 ( October-December, 2014 ) > List of Articles

ORIGINAL ARTICLE

CPAP acceptance and adherence among patients diagnosed with obstructive sleep apnea: A long-term study from eastern India

Susmita Kundu, Supriya Sarkar, Dhrubajyoti Roy, Aloke Gopal Ghoshal, Anupam Patra, Avik Ghoshal, Mita Roy Sengupta

Keywords : Acceptance, CPAP., Obstructive, Sleep apnea,Adherence

Citation Information : Kundu S, Sarkar S, Roy D, Ghoshal AG, Patra A, Ghoshal A, Sengupta MR. CPAP acceptance and adherence among patients diagnosed with obstructive sleep apnea: A long-term study from eastern India. Indian Sleep Med 2014; 9 (4):172-178.

DOI: 10.5958/0974-0155.2015.00004.2

License: CC BY-SA 4.0

Published Online: 00-12-2014

Copyright Statement:  Copyright © 2014; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background: Continuous positive airway pressure (CPAP) is considered to be the gold standard for the management of obstructive sleep apnea (OSA). But poor CPAP adherence is the main limiting factor of the OSA treatment. Objectives: To find out the acceptance and adherence of CPAP use in patients with OSA and the association of personal and disease characteristics of the patients with patterns of CPAP use. Methods: A cross-sectional retrospective study was conducted between June 2014 and December 2014 at the PULSAR, a sleep laboratory in Kolkata, India. Patients diagnosed with OSA between July 2007 and June 2011 at the PULSAR were included and analyzed applying a telephonic questionnaire. Results: A total of 523 patients had undergone polysomnography. Of them, 514 (98.3%) patients were prescribed CPAP; 40(7.6%) were dead, and 36 (6.9%) could not be contacted. of the 438 (83.7%) patients contacted over the phone, 25 (4.8%) refused to participate in the study. The rest, that is, 412 (79%) patients, that agreed to be interviewed were divided into three groups-group I: never used CPAP (134, 25.6%);group II: ever used CPAP (27, 5.2%);and group III: currently using CPAP (252, 48.2%). The mean age of the patients was 50.5 ± 11.2 years; the mean body mass index of the group was 30 ± 5.3. The mean apnea–hypopnea index was 62.3 ± 20.1, with a range of 8.5–127.9. The mean duration of use in ever-used group was 21.6 ± 8.4 months and in current-user group was 54.8 ± 16.0 months. Mechanical discomfort (34.3%) is main cause of non-adherence. Conclusion: About one-third patients prescribed CPAP never initiated the treatment, and those who started reported a high incidence of adherence during the period of this study. A significant correlation was observed between disease severity and the duration of CPAP use.


PDF Share
  1. Martínez-Garcia MA, Soler-Cataluña JJ, Ejarque-Martínez L, et al. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study. Am J Respir Crit Care Med 2009;180:36–41.
  2. Wang Y, Gao W, Sun M, Chen B. Adherence to CPAP in patients with obstructive sleep apneain a Chinese population. Respir Care. 2012;57:238 –243.
  3. Pépin JL, Krieger J, Rodenstein D, et al. Effective compliance during the first 3 months of continuous positive airway pressure. A European prospective study of 121 patients. Am J Respir Crit Care Med. 1999;160:1124– 1129.
  4. Rosenthal L, Gerhardstein R, Lumley A, et al. CPAP therapy in patients with mild OSA: implementation and treatment outcome. Sleep Med. 2000;1:215–220.
  5. Janson C, Noges E, Svedberg-Brandt S, Lindberg E.What characterizes patients who are unable to tolerate continuous positive airway pressure (CPAP) treatment. Respir Med.2000;94:145–149.
  6. Weaver TE, Grunstein RR. Adherence to continuous positive airwaypressure therapy. The challenge to effective treatment. Proc Am Thorac Soc. 2008;5:173–178.
  7. Sawyer AM, Gooneratne N, Marcus CL, Ofer D, Richards KC, Weaver TE. A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev. 2011;15:343–356.
  8. Kribbs NB, Pack AI, Kline LR, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis.1993;147:887–95.
  9. Pieters T, Collad P, Aubert G, Dury M, Delguste P, Rodenstein DO. Acceptance and long-term compliance with nCPAP in patients with obstructive sleep apnea syndrome. Eur Respir J. 1996;9:939–944.
  10. Wolkove N, Baltzan M, Kamel H, Dabrusin R, Palayew M.Long-term compliance with continuous positive airway pressure in patients with obstructive sleep apnea. Can Respir J. 2008;15:365–369.
  11. Rauscher H, Popp W, Wanke T, Zwick H. Acceptance of CPAP therapy for sleep apnea. Chest.1991;100:1019– 1023.
  12. Hoffstein V, Viner S, Mateika S, Conway J. Treatment of obstructive sleep apnea with nasal continuous positive airway pressure. Patient compliance, perception of benefits, and side effects. Am Rev Respir Dis. 1992;145(4 Pt 1):841– 845.
  13. Engleman HM, Martin SE, Douglas NJ. Compliance with CPAP therapy in patients with the sleep apnea/hypopnea syndrome. Thorax.1994;49:263–266.
  14. Meurice JC, Dore P, Paquereau J, et al. Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome. Chest.1994;105:429–433.
  15. Nagarajan R, Ranganathan L, Sundaram A, Charles MI. CPAP therapy in OSA—a gap analysis between recommendation and usage. Indian J Sleep Med. 2012;7:150–156.
  16. McArdle N, Deveraux G, Heidarnejard H, Engleman HM, Mackay TW, Douglas NJ. Long-term use of CPAP therapy for sleep apnoea/hypopnoea syndrome. Am J Respir Crit Care Med. 1999;159:1108–1114.
  17. Stepnowsky CJ Jr, Moore PJ. Nasal CPAP treatment for obstructive sleep apnea: developing a new perspective on dosing strategies and compliance. J Psychosom Res. 2003;54:599–605.
  18. Engleman HM, Wild MR. Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS). Sleep Med Rev. 2003;7:81–99.
  19. Ong KC, Clerk AA. Comparison of the severity of sleep disordered breathing in Asian and Caucasian patients seen at a sleep disorders centre. Respir Med.1998;92:843–848.
  20. Garg R, Singh A, Prasad R, Saheer S, Jabeed P, Verma R. A comparative study on the clinical and polysomnographic pattern of obstructive sleep apnea among obese and nonobese subjects. Ann Thoracic Med. 2012;7(1):26–30.
  21. WHO Expert Consultation. Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet.2004;363:157–163.
  22. Owen GO, Canter RJ, Robinson A. Overnight pulse oximetry in snoring and non-snoring children. Clin Otolaryngol Allied Sci.1995;20:402–406.
  23. Hultcrantz E, Löfstrand-Tideström B, Ahlquist-Rastad J. The epidemiology of sleep related breathing disorder in children. Int J Pediatr Otorhinolaryngol. 1995;32(Suppl):S63–S6.
  24. Ferreira AM, Clemente V, Gozal D, et al. Snoring in Portuguese primary school children. Pediatrics. 2000;106:E64.
  25. Downey R III, Perkin RM, Mac Quarrie J.Nasal continuous positive airway pressure use in children with obstructive sleep apnea younger than 2 years of age. Chest.2000;117(6):1608–1612.
  26. Waldhorn RE, Herrick TW, Nguyen MC, O'Donnell AE, Sodero J, Potolicchio SJ. Long-term compliance with nasal continuous positive airway pressure therapy for OSA.Chest. 1990;97:33–38.
  27. Krieger J, Kurtz D, Petiau C, Sforza E, Trautmann D. Longterm compliance with CPAP therapy in obstructive sleep apnea patients and in snorers. Sleep.1996;19:S136–S143.
  28. Budhiraja R, Parthasarathy S, Drake CL, et al. Early CPAP use identifies subsequent adherence to CPAP therapy. Sleep. 2007;30:320–324.
  29. Engleman HM, Asgari-Jirandeh N, McLeod AL, Ramsay CF, Deary IJ, Douglas NJ.Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest.1996;109:1470–1476.
  30. Schwab RJ, Badr SM, Epstein LJ, et al. An official American Thoracic Society statement: continuous positive airway pressure adherence tracking systems. The optimal monitoring strategies and outcome measures in adults. Am J Respir Crit Care Med. 2013;188:613–620.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.